Zobrazuji výsledky 1 - 16 z 16 pro vyhledávání '"Indonesia"', doba hledání: 0,26 s. Upřesnit hledání
  1. 1
    “…METHODS: A retrospective, hospital-based cohort study of infants aged 1–12 months with vivax malaria was carried out in Timika, Papua province, Indonesia. Risks of admission, death and severe haematological outcomes within 30 days of first presentation were compared between infants who did and did not receive primaquine. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
  2. 2
    “…We compared the platelet counts and clinical correlates of patients with and those without malaria in southern Papua, Indonesia. METHODS: Data were collated on patients presenting to a referral hospital between April 2004 and December 2012. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Severe Malarial Thrombocytopenia: A Risk Factor for Mortality in Papua, Indonesia
  3. 3
    “…A cross-sectional household survey was conducted in southern Papua, Indonesia, using cluster random sampling. Data were recorded using a standardized questionnaire. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Submicroscopic and Asymptomatic Plasmodium Parasitaemia Associated with Significant Risk of Anaemia in Papua, Indonesia
  4. 4
    “…The aim of this study was to quantify the impact of recurrent malaria episodes on morbidity and mortality in Papua, Indonesia. METHODS: We undertook a retrospective analysis of routinely collected data from malaria patients attending the primary referral hospital in Papua, Indonesia, between April 2004 and December 2013. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
  5. 5
    “…BACKGROUND: In Papua (Indonesia), infants with P. falciparum and/or P. vivax malaria are at risk of severe anaemia and death. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial
  6. 6
    “…We investigated temporal trends in malaria-related morbidity and mortality in Papua, Indonesia, before and after introduction of a universal, artemisinin-based antimalarial treatment strategy for all Plasmodium species. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study
  7. 7
    “…We analyzed data from a randomized controlled trial in northwestern Thailand and 2 trials in Papua, Indonesia, to identify and compare risk factors for vivax gametocytemia at enrollment and following treatment. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Gametocyte Dynamics and the Role of Drugs in Reducing the Transmission Potential of Plasmodium vivax
  8. 8
    “…Usual care in Ethiopia does not include radical cure, whereas Afghanistan, Indonesia, and Vietnam prescribe PQ14 without G6PD screening. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure
  9. 9
    “…Selected patients with uncomplicated malaria were recruited in Bangladesh (n = 87), Indonesia (n = 75), and Ethiopia (n = 173); G6PD activity was measured at the initial presentation with malaria and a median of 176 days later (range 140 to 998) in the absence of malaria. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
  10. 10
    “…CONCLUSIONS/SIGNIFICANCE: Plasmodium malariae infection is relatively uncommon in Papua, Indonesia but is associated with significant morbidity from anemia and a similar risk of mortality to patients hospitalized with P. falciparum and P. vivax infection. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Plasmodium malariae Infection Associated with a High Burden of Anemia: A Hospital-Based Surveillance Study
  11. 11
    “…CONCLUSIONS: Unsupervised primaquine for vivax malaria, prescribed according to the current World Health Organization guidelines, was associated with a minimal reduction in the risk of clinical recurrence within 1 year in Papua, Indonesia. New strategies for the effective radical cure of vivax malaria are needed in resource-poor settings.…”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
  12. 12
    “…They were treated with a weekly dose of 0.75 mg/kg primaquine for 8 weeks (PQ8W) plus dihydroartemisinin piperaquine (Indonesia) or chloroquine (Afghanistan, Ethiopia, Vietnam). …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
  13. 13
    “…METHODS: A three-stage, cross-sectional, community survey was used to determine the proportion of moderate or severe anaemia (haemoglobin <7 g/dL) attributable to patent P. vivax, P. falciparum and mixed parasitaemia in Papua, Indonesia. Adjusted population-attributable fractions were calculated from multivariable logistic regression models. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Plasmodium vivax infection: a major determinant of severe anaemia in infancy
  14. 14
    “…We compared the hematological profile of patients with and without malaria in southern Papua, Indonesia. METHODS AND FINDINGS: Clinical and laboratory data were linked for all patients presenting to a referral hospital between April 2004 and December 2012. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Major Burden of Severe Anemia from Non-Falciparum Malaria Species in Southern Papua: A Hospital-Based Surveillance Study
  15. 15
    “…METHODS: This is a multicentre, health care facility-based, randomized, controlled, open-label trial in Bangladesh, Indonesia and Ethiopia. Patients with uncomplicated falciparum malaria, G6PD activity of ≥70% of the adjusted male median (AMM) and haemoglobin levels ≥8g/dl are recruited into the study and randomized to either receive standard schizonticidal treatment plus 7-day high dose primaquine (total dose 7mg/kg) or standard care in a 1:1 ratio. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas—a randomized controlled trial (PRIMA)
  16. 16
    “…METHODS: Data were derived from the IMPROV trial, a randomised, placebo-controlled double blinded trial of high dose primaquine to prevent Plasmodium vivax recurrence conducted in eight study sites in Afghanistan, Ethiopia, Indonesia and Vietnam. At each follow up visit a 13-point symptom questionnaire was completed. …”
    Získat plný text
    Získat plný text
    Získat plný text
    Online Článek Text
    The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
Vyhledávací nástroje: RSS